Giovannelli e Associati with Serim on the merger agreement of the newly formed group of companies
23/11/2021
Giovannelli e Associati with Permeare on the sale of the entire share capital to Investindustrial
23/12/2021Giovannelli e Associati with Genenta Science S.p.A. on its IPO and listing on the Nasdaq Capital Market
il
Genenta Science S.p.A., a company active in the development of gene therapies for the fight against cancer, is the first Italian biotech company to be listed on the US hi-tech Nasdaq Capital Market.
The team of Giovannelli e Associati was led by partners Andrea Bartolucci and Gianvittorio Giroletti Angeli assisted by associates Marco Tapparo, Annalisa Zorzut and Camilla Lanzafame for the Italian capital market and corporate aspects, by partner Riccardo Pontremoli for administrative/regulatory law aspects and by of counsel Giuseppe Matarazzo for labour law profiles.
Read More:
Media correlati
14/03/2023
08/03/2023
